The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/jnp.15.3.354

To investigate a possible effect of the apolipoprotein (APOE) ϵ4 allele on memory decline in Alzheimer's disease (AD), we examined 64 AD patients with the APOE ϵ3/3, ϵ3/4, or ϵ4/4 allele using the Alzheimer Disease Assessment Scale-Cognitive subscale (ADAS-Cog) and its subtests at the initial examination and at the 1-year follow-up visit. One-year changes in the scores of the Word Recall subtest, Word Recognition subtest, and total ADAS-Cog were significantly correlated with the number of APOE ϵ4 alleles after controlling for the effects of age, sex, education, test interval, and baseline scores. Findings revealed that APOE ϵ4 allele is related to an accelerated memory decline in AD.